132 related articles for article (PubMed ID: 36998632)
1. Eczema Monkeypoxicum in a Female Patient With Atopic Dermatitis.
Napoli E; Frizzell M; Gravell C; Vallejo S; Theodore S; Chen K; Siddiqui H; Dunn J; Marrufo D; Cadena J; Danaher PJ
Open Forum Infect Dis; 2023 Mar; 10(3):ofad072. PubMed ID: 36998632
[TBL] [Abstract][Full Text] [Related]
2. Eczema monkeypoxicum: Report of monkeypox transmission in a patient with atopic dermatitis.
Xia J; Huang CL; Chu P; Kroshinsky D
JAAD Case Rep; 2022 Nov; 29():95-99. PubMed ID: 36212897
[No Abstract] [Full Text] [Related]
3. Intravenous tecovirimat treatment of oral monkeypox lesions in a patient with HIV-1.
Chen WH; Axell-House DB
J Med Virol; 2023 Sep; 95(9):e29078. PubMed ID: 37665172
[TBL] [Abstract][Full Text] [Related]
4. Severe monkeypox with superimposed bacterial infection in an immunocompetent patient: A case report.
Manoharan A; Braz BX; McBride A; Hernandez S; Balfour M; Quiroz T; Powell A; Rodriguez A; Morris S; Gonzales-Zamora JA
IDCases; 2022; 30():e01626. PubMed ID: 36345426
[TBL] [Abstract][Full Text] [Related]
5. Overview of the regulatory approval of tecovirimat intravenous formulation for treatment of smallpox: potential impact on smallpox outbreak response capabilities, and future tecovirimat development potential.
Russo AT; Grosenbach DW; Honeychurch KM; Long PG; Hruby DE
Expert Rev Anti Infect Ther; 2023 Mar; 21(3):235-242. PubMed ID: 36728515
[TBL] [Abstract][Full Text] [Related]
6. Interim Clinical Treatment Considerations for Severe Manifestations of Mpox - United States, February 2023.
Rao AK; Schrodt CA; Minhaj FS; Waltenburg MA; Cash-Goldwasser S; Yu Y; Petersen BW; Hutson C; Damon IK
MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(9):232-243. PubMed ID: 36862595
[TBL] [Abstract][Full Text] [Related]
7. A Glance at the Development and Patent Literature of Tecovirimat: The First-in-Class Therapy for Emerging Monkeypox Outbreak.
Almehmadi M; Allahyani M; Alsaiari AA; Alshammari MK; Alharbi AS; Hussain KH; Alsubaihi LI; Kamal M; Alotaibi SS; Alotaibi AN; Aldhafeeri AA; Imran M
Viruses; 2022 Aug; 14(9):. PubMed ID: 36146675
[TBL] [Abstract][Full Text] [Related]
8. Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).
Wharton M; Strikas RA; Harpaz R; Rotz LD; Schwartz B; Casey CG; Pearson ML; Anderson LJ; ;
MMWR Recomm Rep; 2003 Apr; 52(RR-7):1-16. PubMed ID: 12710832
[TBL] [Abstract][Full Text] [Related]
9. Successful Outcome after Treatment with Cidofovir, Vaccinia, and Extended Course of Tecovirimat in a Newly-Diagnosed HIV Patient with Severe Mpox: A Case Report.
Martinez AE; Frattaroli P; Vu CA; Paniagua L; Mintz J; Bravo-Gonzalez A; Zamudio P; Barco A; Rampersad A; Lichtenberger P; Gonzales-Zamora JA
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992234
[TBL] [Abstract][Full Text] [Related]
10. Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox - United States, 2022.
Minhaj FS; Petras JK; Brown JA; Mangla AT; Russo K; Willut C; Lee M; Beverley J; Harold R; Milroy L; Pope B; Gould E; Beeler C; Schneider J; Mostafa HH; Godfred-Cato S; Click ES; Borah BF; Galang RR; Cash-Goldwasser S; Wong JM; McCormick DW; Yu PA; Shelus V; Carpenter A; Schatzman S; Lowe D; Townsend MB; Davidson W; Wynn NT; Satheshkumar PS; O'Connor SM; O'Laughlin K; Rao AK; McCollum AM; Negrón ME; Hutson CL; Salzer JS; ;
MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(36):1155-1158. PubMed ID: 36074752
[TBL] [Abstract][Full Text] [Related]
11. Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models.
Achdout H; Lustig S; Israely T; Erez N; Politi B; Tamir H; Israeli O; Waner T; Melamed S; Paran N
Vaccine; 2017 Jul; 35(33):4245-4254. PubMed ID: 28625523
[TBL] [Abstract][Full Text] [Related]
12. Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children.
Parker JJ; Sugarman JL; Silverberg NB; Gonzalez ME; Ramien ML; Teng JMC; Paller AS
Pediatr Dermatol; 2021 Nov; 38(6):1500-1505. PubMed ID: 34647354
[TBL] [Abstract][Full Text] [Related]
13. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
14. Acute vesiculopapular rash in the setting of atopic dermatitis.
Miller RA; McGrann J; Jassim AD; Miller TN
S D Med; 2010 Dec; 63(12):407-9. PubMed ID: 21265484
[TBL] [Abstract][Full Text] [Related]
15. Hand eczema and long-term prognosis in atopic dermatitis.
Rystedt I
Acta Derm Venereol Suppl (Stockh); 1985; 117():1-59. PubMed ID: 2931938
[TBL] [Abstract][Full Text] [Related]
16. Correlation of nipple eczema in pregnancy with atopic dermatitis in Northern India: a study of 100 cases.
Puri A; Sethi A; Puri KJPS; Sharma A
An Bras Dermatol; 2019; 94(5):549-552. PubMed ID: 31777355
[TBL] [Abstract][Full Text] [Related]
17. Monkeypox infection and resolution after treatment with tecovirimat in two patients with HIV disease.
Beatty NL; Small C; Degener T; Henao Martinez AF
Ther Adv Infect Dis; 2022; 9():20499361221138349. PubMed ID: 36440456
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis: Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials.
Simpson EL; Papp KA; Blauvelt A; Chu CY; Hong HC; Katoh N; Calimlim BM; Thyssen JP; Chiou AS; Bissonnette R; Stein Gold LF; Wegzyn C; Hu X; Liu M; Liu J; Tenorio AR; Chu AD; Guttman-Yassky E
JAMA Dermatol; 2022 Apr; 158(4):404-413. PubMed ID: 35262646
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
[TBL] [Abstract][Full Text] [Related]
20. Estimating the prevalence of aero-allergy and/or food allergy in infants, children and young people with moderate-to-severe atopic eczema/dermatitis in primary care: multi-centre, cross-sectional study.
Dhami S; Sheikh A
J R Soc Med; 2015 Jun; 108(6):229-36. PubMed ID: 25567768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
